RNS Number : 4057S
NetScientific PLC
14 June 2024
 

http://netscientific.net/addons/default/themes/bootstrap/img/logo.png 

 


NetScientific plc

 

("NetScientific" or the "Company")

 

Director/PDMR Shareholding

 

NetScientific Plc (AIM: NSCI), the deeptech and life sciences VC investment group, announces that today, Mr Ed Hooper (Executive Director) purchased 20,000 ordinary shares in the capital of NetScientific Plc ("Ordinary Shares") through his Self-Invested Personal Pension.

 

Following such purchase, Ed Hooper is interested in 109,000 Ordinary Shares, representing 0.46 per cent. of the entire issued share capital of the Company.

 

The information below, set out in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Mr Edward Hooper

2

Reason for the notification

a)

Position/status

Director

b)

 

Initial notification /Amendment

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

NetScientific plc

b)

LEI

213800N5WD46G1Y7I458

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

NSCI 5p Ordinary Shares

 

  

GB00BN4R5Q82

b)

Nature of the transaction 

Purchase of Ordinary Shares into SIPP

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

£0.678

20,000 shares

 

d)

 

Aggregated information

 - Aggregated volume

 

 - Price

 

 

 

Price

 

Volume

£0.678

20,000 shares

e)

 

Date of the transaction

13 June 2024

f)

 

Place of the transaction

UK AIM

 

#  #  #

 

For more information, please contact:

NetScientific


Ilian Iliev, CEO

Via Belvedere Communications

 

 

Panmure Gordon (UK) Limited (NOMAD and Broker)

 

Emma Earl / Will Goode / Freddy Crossley / Mark Rogers (Corporate Finance)

Rupert Dearden (Corporate Broking)

+44 (0)20 7886 2500



Belvedere Communications

John West / Llewellyn Angus / Lily Pearce

 

+44 (0)20 7653 8702

 

About NetScientific

NetScientific plc (AIM: NSCI) is a deeptech and life sciences VC investment group with an international portfolio of innovative companies.

NetScientific identifies, invests in, and builds high growth companies in the UK and internationally. The company adds value through the proactive management of its portfolio, progressing to key value inflection points, and delivering investment returns through partial or full liquidity events.

NetScientific differentiates itself by employing a capital-efficient investment approach, making judicial use of its balance sheet and syndicating investments through its wholly owned VC subsidiary, EMV Capital. The group secures a mixture of direct equity stakes and carried interest stakes in its portfolio of companies, creating a lean structure that can support a large portfolio.

NetScientific is headquartered in London, United Kingdom, and is admitted to trading on AIM, a market operated by the London Stock Exchange.

www.netscientific.net

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSFSEFDELSESM